<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Protein Technologies Inc. for $4,950.02 on March 3, 2016, with final completion on April 30, 2016. The order covers repair of a hard-disk on a Protein Technologies peptide synthesizer. Work is performed in Tucson, Arizona. The award is firm fixed price with no small business set-aside.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Protein Technologies Inc. for $107,107.16 on June 29, 2020, to acquire a PurePep Chorus peptide synthesizer (110/230 VAC). Performance will be completed in Tucson, Arizona, with an ultimate completion date of August 28, 2020. The order was issued under firm fixed price terms following a pre-solicitation opportunity posted June 15, 2020, with a due date of June 23, 2020.</p>
<p>This is a $4,441.00 purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Mimotopes PTY LTD for a set of 165 peptides, designated as PSACM0165-01 PEPSET OF 165 PEPTIDES. The contract has a performance period through October 30, 2007 and was awarded on September 12, 2007. The contract does not have a set-aside designation.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) awarded a $45,390.05 firm-fixed-price purchase order to Biotage, LLC for a base year plus four option years of maintenance and support services for the Alstra Peptide Synthesizer. This equipment is used by the NIDDK's Laboratory of Chemical Physics to conduct research on protein folding, ligand binding, and peptide aggregation. The solicitation was not competitively bid, as...
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Arizona State University for $29,125 on September 2, 2015, for RNA sequencing of 24 muscle samples and adipose and muscle tissue testing. Performance is located in Tempe, Arizona, with an ultimate completion date of September 3, 2016.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $24,545.41 on August 10, 2016. The order procures various laboratory equipment on a firm fixed price basis. Place of performance is Carlsbad, California. The order is scheduled for completion by September 30, 2016.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Chem-Master International, Inc. for $13,900 on March 3, 2021, with ultimate completion by April 17, 2021. The order is firm fixed price with no set-aside. Work is performed in Smithtown, New York. The purchase covers chemical compound synthesis in support of NIDDK research activities.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Synteract, Inc. for $28,956.50 on November 20, 2018. The order was firm fixed price with no set-aside applied. Place of performance was Bethesda, Maryland. The contract expired on May 19, 2019.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Nanotemper Technologies Inc. for $12,674.00 on September 17, 2020, with completion by September 30, 2020. The order is firm fixed price with no small business set-aside. Performance occurs in South San Francisco, California. The awardee is a self-certified small disadvantaged business.</p>